Michael S. Gunter, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 300 shares at $4.85 ($1K) on 2011-06-13, disclosed to the SEC on 2012-02-14.
Open-market purchase of $1k HRT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| HRT | BUY | 2012-12-10 | $239 | — | Filing → |
| HRT | BUY | 2011-12-15 | $2K | — | Filing → |
| HRT | BUY | 2011-11-30 | $8K | — | Filing → |